Additional file 2: of A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers

Nagaraja, Vivek; Spino, Cathie; Bush, Erica; Tsou, Pei-Suen; Domsic, Robyn T.; Lafyatis, Robert; Frech, Tracy; Gordon, Jessica K.; Steen, Virginia D.; Khanna, Dinesh

doi:10.6084/m9.figshare.9765989.v1

13075_2019_1979_MOESM2_ESM.pdf (681.71 kB)

Additional file 2: of A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers

journal contribution

posted on 2019-09-04, 04:54 authored by Vivek Nagaraja, Cathie Spino, Erica Bush, Pei-Suen Tsou, Robyn T. Domsic, Robert Lafyatis, Tracy Frech, Jessica K. Gordon, Virginia D. Steen, Dinesh Khanna

Further details on the statistical analysis. (PDF 681 kb)

Funding

Bayer Corporation

History

Usage metrics

Keywords

Systemic sclerosis Digital ulcers Riociguat Clinical trial

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: of A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers

Funding

Bayer Corporation

History

Usage metrics

Categories

Keywords

Licence

Exports